Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy5 maleimide non sulfonated 5mg'

Search results for: 'cy5 maleimide non sulfonated 5mg'

Items 31-40 of 41

Page
per page
  1. TUG-770
    A3895 TUG-770
    Target: Free Fatty Acid Receptors
    Summary: FFA1/GPR40 agonist
      insoluble in H2O; ≥11.85 mg/mL
  2. AMD-070
    A3173 AMD-070
    Target: CXCR
    Summary: CXCR4 antagonist,potent and selective
      ≥17.45 mg/mL
  3. TAK-875
    A8339 TAK-875
    Target: GPR40
    Summary: GPR40 agonist
      ≥26.25 mg/mL
  4. MK-571 sodium salt hydrate
    B8031 MK-571 sodium salt hydrate
     3 Citation
    Target: CysLT1
    Summary: CysLT1 receptor antagonist
      ≥10.3 mg/mL
  5. PF-543
    A3717 PF-543
     1 Citation
    Target: Sphingosine kinases (SphKs)
    Summary: SphK1 inhibitor,cell-permeate,potent and selective
      ≥23.3 mg/mL
  6. Ki16198
    B1591 Ki16198
    Target: LPA Receptors
    Summary: LPA antagonist
  7. Istradefylline (KW-6002)
    A8454 Istradefylline (KW-6002)
    Target: Adenosine A2A Receptors
    Summary: Selective A2A receptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥8.78 mg/mL
  8. AVE 0991
    B1007 AVE 0991
     1 Citation
    Target: Angiotensin AT1 Receptors
    Summary: Agonist of angiotensin-(1-7) receptor
      ≥29.04 mg/mL
  9. Clozapine N-oxide (CNO)
    A3317 Clozapine N-oxide (CNO)
     1 Citation
    Target: DREADD Ligands
    Summary: Metabolite of clozapine, used in chemogenetics.
      insoluble in EtOH; ≥17.15 mg/mL
  10. MPEP Hydrochloride
    A3633 MPEP Hydrochloride
    Target: Glutamate (Metabotropic) Group I Receptors
    Summary: MGlu5 receptor antagonist
      Soluble in DMSO

Items 31-40 of 41

Page
per page
Shop By
Now Shopping by
  1. Category GPCR/G protein Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. 5-HT Receptor 3item
  2. Adenosine Receptor 3item
  3. Adenosine Kinase 1 item
  4. Adrenergic Receptor 4item
  5. Angiotensin Receptor 3item
  6. Cannabinoid Receptor 1 item
  7. CaSR 1 item
  8. CCR2 1 item
  9. CRF1 Receptors 1 item
  10. CXCR 4item
  11. Free Fatty Acid Receptors 3item
  12. Glucagon Receptor 1 item
  13. Leukotriene Receptor 2item
  14. LPA Receptor 3item
  15. mGluR 1 item
  16. MT Receptor 1 item
  17. P2Y Receptor 1 item
  18. Prostanoid Receptors 2item
  19. Protease-Activated Receptors 1 item
  20. S1P receptor 2item
  21. NK Receptor 1 item
  22. S1P receptor inhibitor 1 item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Adenosine A2A Receptors 2item
  2. CXCR 4item
  3. LPA Receptors 3item
  4. Purinergic (P2Y) Receptors 1 item
  5. CCR 1 item
  6. Angiotensin AT2 Receptors 2item
  7. Adenosine Kinases 1 item
  8. CysLT1 1 item
  9. 5-HT2 Receptors 1 item
  10. S1P receptors 2item
  11. Insulin and Insulin-like Receptors 1 item
  12. Prostaglandin EP receptors 1 item
  13. Sphingosine kinases (SphKs) 1 item
  14. NK1 Receptors 1 item
  15. Free Fatty Acid Receptors 2item
  16. Melatonin Receptors 1 item
  17. Adenosine A2B Receptors 1 item
  18. Glutamate (Metabotropic) Group I Receptors 1 item
  19. Leukotriene and Related Receptors 1 item
  20. Angiotensin AT1 Receptors 1 item
  21. Na /Ca2 Exchangers (NCXs) 1 item
  22. GPR40 1 item
  23. Glucagon Receptors 1 item
  24. DREADD Ligands 1 item
  25. PARs 1 item
  26. adrenoceptor 1 item
  27. cannabinoid receptor 1 item
  28. Calcium-Sensing Receptors (CaSRs) 1 item
  29. Prostanoid Receptors 1 item
  30. CRF1 Receptors 1 item
Reported Experiments
  1. Animal Experiments 40item
  2. Cell Experiments 26item
Related Disease
  1. Breast Cancer 3item
  2. Cancer 6item
  3. Colorectal Cancer 2item
  4. Inflammatory Diseases 3item
  5. Melanoma 1 item
  6. Pancreatic Cancer 1 item
  7. Prostate Cancer 1 item
  8. Renal Cancer 1 item
  9. Sleep Disorders 1 item
  10. Type 2 Diabetes 4item